The Missouri Department of Health and Senior Services plays a critical role in maintaining public health, with the MO 580 1589 form serving as a pivotal tool in the fight against Tuberculosis (TB). This comprehensive form is designed to record and manage TB testing, capturing a wide spectrum of information that includes patient demographics, the reason for testing, history of tuberculin tests, and risk factors indicating the likelihood of TB infection. The form meticulously documents results from current tuberculin PPD Mantoux tests or X-rays, ensuring precise tracking of TB exposure or infection status. Additionally, it facilitates the monitoring of treatment and recommendations, encapsulating details on latent TB infections (LTBI), medication provided, and the provider's information. Notably, it also covers patient consent for the Tuberculin Skin Test (TST) and potential reasons for treatment refusal or non-initiation, further showcasing the form's importance in TB prevention and control efforts. The inclusion of a section for documenting adverse effects during treatment underscores the comprehensive approach to patient care and safety. By capturing such exhaustive data, the MO 580 1589 form plays a vital role in the management and containment of Tuberculosis, serving as a cornerstone for health professionals in their ongoing battle against this infectious disease.
Question | Answer |
---|---|
Form Name | Form Mo 580 1589 |
Form Length | 2 pages |
Fillable? | No |
Fillable fields | 0 |
Avg. time to fill out | 30 sec |
Other names | TBC 4 missouri department of health and senior services tuberculosis testing record form |
mIssourI dePartment of HealtH and senIor servIces
tuberculosis testing record
a. patient information |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
e. reason for testing |
|
|
|
|
|
|
|
|
|
|
|||||||
name (last, fIrst, mIddle InItIal) |
|
|
|
|
|
|
|
|
|
|
PHone numBer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
contact to tB case |
|
employment |
medically referred |
symptomatic |
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Immigration |
|
|
Insurance |
educational enrollment |
resident |
|||||||||
Inmate numBer |
|
|
|
|
student Id numBer |
|
|
socIal securIty numBer |
|
|
||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
address/street |
|
|
|
|
|
|
|
|
cIty |
|
|
|
|
|
|
|
|
zIP code |
emPloyer/resIdence |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
long term care facility |
|
department of corrections |
Health care facility |
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
substance abuse center |
|
school/day care |
|
county Jail |
||||||||||||
county |
|
|
|
|
date of BIrtH |
|
WeIgHt |
|
|
|
sex |
|
|
|
||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
male |
female |
other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
race |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I consent to a tuberculin skin test (tst) for the above reason(s). I understand I am to have the skin test read in |
||||||||||||||
White |
Black |
asian/Pacific Islander |
american Indian/alaskan native |
hours by the designated reader/interpreter. If I do not return in |
||||||||||||||||||||||||||||||||
tst |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
etHnIc orIgIn |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
client’s/guardian signature |
|
|
|
|
|
|
|
|
|
date |
||||
Hispanic |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
occuPatIon |
|
|
|
|
|
|
|
|
|
alIen numBer |
|
|
|
|
|
|
|
|
|
f. risk factors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Please cHeck all tHat aPPly |
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contact to TB Case – |
|
|
|
|
I.V. Drug User |
|
|
|
|
Foreign Born Where TB is Common |
|||||
Place of emPloyment |
|
|
|
|
|
|
|
|
dcn numBer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
High |
Medium |
Low |
|
Homeless |
|
|
|
|
Employee of Dept. of Corrections |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Abnormal Chest |
|
|
|
|
Migrant Worker |
|
Employee of other Correctional Facility |
||||||||||
b. history of tuberculin test |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Have you ever Had a Bcg vaccine? |
|
|
Have you ever Had a tuBerculIn test? |
|
|
WHen/date |
Alcoholic |
|
|
|
|
|
Diabetes Mellitus |
|
Employee of Long Term Care Facility |
|||||||||||||||||||||
no |
yes |
unknown |
|
no |
|
yes |
|
|
unknown |
|
|
Younger Than 4 Years of Age |
|
Silicosis |
|
|
|
|
Employee of Mental Health Facility |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underserved/Low Income |
|
|
|
Provide Health Care Service |
Resident of Dept. of Corrections |
||||||||||||
results In mm of PrevIous skIn test |
|
|
|
tyPe of test |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Teaches High Risk Groups |
|
Resident of Other Correctional Facility |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prolonged Corticosteroid Therapy |
|
No Known Risk Factors |
|
Resident of Long Term Care Facility |
|||||||||||||||||
c. current tuberculin ppd mantouX |
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
date/tIme admInIstered |
|
manufacturer |
|
|
|
date/tIme admInIstered |
|
manufacturer |
|
10% or More Below Ideal Body Weight |
|
Immunosuppressed |
|
Resident of Mental Health Facility |
||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Skin Test Converter With 2 Years |
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
date/tIme read |
|
|
lot numBer |
|
|
|
date/tIme read |
|
|
|
|
lot numBer |
|
g. treatment/recommendations |
|
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
status |
|
|
|
latent tB InfectIon (ltBI) |
|
|
medIcatIon ProvIded By |
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
close |
open |
|
no |
yes |
|
|
|
Private Provider |
Health dept. |
||||||||
results In mm |
|
|
admIn. sIgnature |
|
|
|
results In mm |
|
|
|
|
admIn. sIgnature |
|
|
|
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
h. medication |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Igra test done |
|
|
date/tIme |
|
results |
|
|
|
|
|
|
|
|
|
|
drug/mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
no |
yes |
|
|
|
|
|
|
Positive |
|
|
|
|
|
|
negative |
|
InH _____ |
|
rifampin _____ |
InH/rPt_____ |
other_____ |
|||||||||||||||
(Igra=t spot or quantiferon) |
|
|
|
|
|
Borderline |
|
|
|
|
|
|
Indeterminate |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
frequency |
|
|
|
|
|
|
|
duratIon (In montHs) |
start date |
||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
cHest |
|
date done |
|
results |
|
|
|
|
|
|
fIndIngs |
|
daily |
Weekly |
|
2 or 3 times Weekly by dot |
|
|
|
|
|
|
|
|||||||||||||
no |
yes |
|
|
|
|
|
|
normal |
|
abnormal |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
reason treatment not started |
|
|
|
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
d. health care provider |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
name/facIlIty |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient refuses therapy |
Physician did not order |
medical contraindication |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previously treated (documentation Provided) |
|
|
|
|
|
|
|
|
||||||
address |
|
|
|
|
|
|
|
|
|
|
|
|
|
PHone numBer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
comments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
reported by |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
name/facIlIty |
|
|
|
|
|
|
|
|
|
|
|
|
|
PHone numBer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
address |
|
|
|
|
|
|
|
|
|
|
|
|
|
rePort date |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
mo |
please complete back of form for treatment (for rePortIng dIsease use |
preventive treatment monitoring |
continuation |
PatIent’s name |
|
|
|
|
|
|
date of BIrtH |
|
|
note: 9 months of InH treatment is recommended for all |
||||||
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
infected persons |
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
encounter date: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
allergIes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
nka |
yes list: |
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
medications |
|
mg |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
InH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
rifampin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
InH/rPt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
adverse effects |
adverse |
adverse |
adverse |
adverse |
adverse |
adverse |
adverse |
adverse |
adverse |
adverse |
adverse |
adverse |
||||
effects |
effects |
effects |
effects |
effects |
effects |
effects |
effects |
effects |
effects |
effects |
effects |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
fatigue, Weakness |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
fever, chills |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
loss of appetite |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
nausea |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
vomiting |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Jaundice |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
dark Brown urine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
rash |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Itching |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Joint Pain |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
numbness/tingling |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
abdominal discomfort |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
otHer medIcatIons |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
liver enzyme |
lfts |
lfts |
lfts |
lfts |
lfts |
lfts |
lfts |
lfts |
lfts |
lfts |
lfts |
lfts |
||||
collection data |
y n |
y n |
y n |
y n |
y n |
y n |
y n |
y n |
y n |
y n |
y n |
y n |
||||
|
|
|
|
alt |
alt |
alt |
alt |
alt |
alt |
alt |
alt |
alt |
alt |
alt |
alt |
|
alt results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ast |
ast |
ast |
ast |
ast |
ast |
ast |
ast |
ast |
ast |
ast |
ast |
|
ast results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
next encounter date |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
comments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
evaluator
name/signature/title
mo |
please send to your local health department |
|
|
|
client is lost to |
|
Provider decision to stop |
|
Physician declined Preventive therapy |
|
|
|
date |
completion of treatment |
treatment stoPPed (montH/day/year) |
|
|
|
|
Patient refuses Preventive therapy |
|
|
|||
|
|
|
|
|
|
||||||
active tB developed |
adverse effect of medicine |
no therapy needed |
|
|
|||||||
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
treatment comPleted (montH/day/year) |
reason treatment stoPPed |
completed treatment |
death |
client moved |
client chose to stop |
HealtH care ProvIder sIgnature |
|||
|
|
|
|
|
|
|